Shandong Pharmaceutical Glass Co.Ltd (SHA: 600529)

Market Cap	18.40B
Revenue (ttm)	5.13B
Net Income (ttm)	882.00M
Shares Out	663.61M
EPS (ttm)	1.33
PE Ratio	20.84
Forward PE	16.40
Dividend	0.60 (2.16%)
Ex-Dividend Date	Oct 11, 2024

Volume	38,698,772
Open	26.62
Previous Close	26.70
Day's Range	26.49 - 28.34
52-Week Range	21.61 - 32.33
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 25, 2025

About Shandong Pharmaceutical Glass Co.Ltd

Shandong Pharmaceutical Glass Co.Ltd manufactures and sells pharmaceutical glass packaging and butyl rubber series products in China. It offers pharma glass packaging products, such as molded injection glass vials, food-grade bottles, clear cosmetic bottles, cobalt blue and green bottles, tubular glass vials, ampoules, glass tubing products, amber glass bottles, and other borosilicate glass products; butyl rubber stoppers; prefilled syringes, plastic and aluminum caps, plastic caps, and plastic bottles; and dropper caps and Teflon coated rubber...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1970
• Employees: 6,473
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600529

Financial Performance

In 2023, Shandong Pharmaceutical Glass Co.Ltd's revenue was 4.98 billion, an increase of 18.98% compared to the previous year's 4.19 billion. Earnings were 775.80 million, an increase of 25.48%.